| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| Company: MJH Life Sciences |
| Recipient: You |
| Company: Research to Practice |
| Recipient: You |
| Company: Aptitude Health |
| Recipient: You |
|
| Consulting or Advisory Role |
| Company: Roche/Genentech |
| Recipient: You |
| Company: FibroGen |
| Recipient: You |
| Company: Merus |
| Recipient: You |
| Company: GRAIL |
| Recipient: You |
| Company: Astellas Pharma |
| Recipient: You |
| Company: Tango Therapeutics |
| Recipient: You |
| Company: RenovoRx |
| Recipient: You |
| Company: Legend Biotech |
| Recipient: You |
| Company: Corcept Therapeutics |
| Recipient: You |
| Company: Revolution Medicines |
| Recipient: You |
| Company: Jazz Pharmaceuticals |
| Recipient: You |
| Company: Gilead Sciences |
| Recipient: You |
| Company: Pfizer |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Genentech/Roche |
| Recipient: Your Institution |
| Company: Apexigen |
| Recipient: Your Institution |
| Company: Astellas Pharma |
| Recipient: Your Institution |
| Company: Leap Therapeutics |
| Recipient: Your Institution |
| Company: BioMed Valley Discoveries |
| Recipient: Your Institution |
| Company: Crystal Genomics |
| Recipient: Your Institution |
| Company: Verastem |
| Recipient: Your Institution |
| Company: Revolution Medicines |
| Recipient: Your Institution |
| Company: Arcus Biosciences |
| Recipient: Your Institution |
| Company: Novartis |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| not answered |
|
|
| (OPTIONAL) Open Payments Link |
| not answered |
|
|